Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Rice AS, Dworkin RH, McCarthy TD, Anand P, et al. EMA401, an orally administered highly selective angiotensin II type 2 receptor antagonist, as a novel treatment for postherpetic neuralgia: a randomised, double-blind, placebo-controlled phase 2 clinical trial. Lancet 2014;383:1637-47.
PMID: 24507377


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016